Status:

ACTIVE_NOT_RECRUITING

An Integrated Intervention Involving Recovery Coaching and Cognitive Behavioral Therapy for Opioid Use Disorder

Lead Sponsor:

Prisma Health-Upstate

Collaborating Sponsors:

Clemson University

National Institute on Drug Abuse (NIDA)

Conditions:

Standard of Care

Standard of Care + CBT4CBT

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The Overcome II study is a randomized controlled trial among adults receiving sublingual buprenorphine to help prevent or reduce illicit drug use. The study outcomes will be compared between three tre...

Detailed Description

Buprenorphine has proven to be an effective pharmacologic strategy for treating OUD. However, buprenorphine is unlikely to give greater overall protection because of the shorter duration of treatment....

Eligibility Criteria

Inclusion

  • Adults (≥18 years of age);
  • DSM-V diagnosis of OUD, confirmed via electronic medical record review;
  • Currently receiving SL buprenorphine/ naloxone and/or buprenorphine HCL;
  • Initiated SL buprenorphine within the last 30 days;
  • Willing to accept a random assignment to either treatment arm:
  • Adequate computer skills

Exclusion

  • Severe medical or psychiatric disability that could impair the ability to perform study related activities (determined by the clinician);
  • Pregnancy, planning conception, or breast-feeding for female participants;
  • Inability to independently read and/or comprehend the consent form or other study materials;
  • Inability to read/speak English (inability to independently read and comprehend the consent form or other study materials);
  • Current suicidal ideation based on the Patient Health Questionnaire-9
  • Have taken or received any prescribed buprenorphine product within 30 days prior to the current treatment episode.

Key Trial Info

Start Date :

October 5 2023

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

May 31 2026

Estimated Enrollment :

92 Patients enrolled

Trial Details

Trial ID

NCT06102200

Start Date

October 5 2023

End Date

May 31 2026

Last Update

August 28 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Greenville Health System

Greenville, South Carolina, United States, 29605